Sarcoidosis Answers for Physicians, Nurses and Patients

Here at SarcInfo, between 2002 and 2004, we identified the cause of Sarcoidosis, and successfully trialled a curative antimicrobial therapy. During 2005 and 2006 the US FDA designated the antibiotics Clindamycin and Minocycline as Orphan Products in the treatment of Sarcoidosis, and studies are ongoing elsewhere.

For information about this breakthrough, please post your questions at the current study-site, or the Autoimmunity Research Foundation.
 
This archive of the historic study is maintained by volunteers from the Foundation. The material here provides useful background, but much of it is now out-of-date.

** Patient Tutorials **

 Click here to read "WHY DID I GET SARCOIDOSIS? WHY ME? 

  Click here to read "REMISSION IN SARCOIDOSIS"  

 How a Pathologist can see Bacteria causing Sarcoidosis 

"How does Doctor measure my ACE, and my D-metabolites?"

 Weaning from Prednisone

 Protecting your eyes in Sarcoidosis

Vit.D and Calcium in Sarcoidosis

Hypervitaminosis D Symptoms    The SarcInfo F.A.Q.

Medical Abbreviations          CBC Radio Show

Protocol Phase 1-First 3 months

 

** Papers for Physicians **

Antibacterial Therapy induces Remission 

Implications for Autoimmune Disease 
(Here is Fulltext preprint)

Antibacterial mechanisms for ARBs 

Antibiotics in Sarcoidosis- The 1st Year 

Rationale for abx in Sarcoidosis 

1,25-D and Angiotensin II

"New Treatments Emerge.."

Jarisch-Herxheimer in Sarcoidosis

Vit.D and Calcium in Sarcoidosis

Protocol Phase 1-First 3 months

The NIH ACCESS Study finds Sarcoidosis does not go away - Click here to see, and print, the brochure


 Main Menu  |  Search  |  Log In   Newer Topic  |  Older Topic 
 Granulomas and inflammation
Author: Ken (---.proxy.aol.com)
Date:   03-25-02 18:26

http://www.pulmonarychannel.com/sarcoidosis/

 
 Re: Granulomas
Author: Admin (---.gtecablemodem.com)
Date:   03-26-02 06:53

Ken,
This is an easy-to-read reference but it needs explanation.

IMO it is wrong to focus on the formation of granuloma by macrophages and forget to ask why they become fibrotic in a sarc patients body yet they they are re-assimilated into the body of a 'normal' individual. Marcrophages have a specific job to do, in everybody, and they perform that job well. It is to clean up damaged or dying cells. Everybody has macrophages.

A sarc patient should not focus on the macrophages and granuloma, IMO, but on the formation of the inflammatory cytokines, kinins and the other chemicals, both within the macrophages and from other sources. Once the granuloma have become "old", especially if they have become fibrotic, they no longer affect our immune system. Our body becomes tolerant of them. The old granuloma themselves are no longer part of 'the inflammation'.

In response to an new immune challenge, the T-lymphocytes go into action. T-lymphocytes cause monocytes to produce ACE, ACE catalyses some amino acids into Angiotensin II, which in turn creates many of the inflammatory chemicals that allow macrophages (which are actually groups of monocytes) to break down the diseased tissue. We now have some new safe drugs that can stop the Angiotensin II from releasing those inflammatory chemicals.

It seems to me to be more useful to protect the tissue from inflammation so that it doesn't die - and the macrophages don't have to clean it up - and the macrophages don't then agglomerate into granuloma - than to focus on the granuloma themselves. Granuloma are only the end-product of an inflammation process that can be stopped at its source, at least substantially stopped, using relatively innocuous new drugs.

Angiotensin II also acts at other sites in the body to help the regeneration (apoptosis) of new tissue. This is an emerging field of research, and much of the published data on tissue regeneration is being obtained from animal experiments with relation to heart failure. But you might find these following references interesting. All of them relate to the beneficial effects on inflammed and diseased tissue resulting from Angiotensin II blockade using one of the new 'sartan' drugs such as Diovan (Valsartan). Particularly note the reversal of renal fibrosis and delaying of diabetic nephropathy in the references below. There is no fundamental reason the sartans should not have similar effects in sarcoidosis.

But any sarc patient contemplating the use of these drugs needs to show their doctor a copy of our manuscript on the psychotic effects of valsartan in sarc patients - Angiotensin II therapy, although very safe, affects sarcoid patients profoundly (as you would expect). It affects the brain as well as the inflammed tissue. With proper dosing can the psychotic effects be extremely beneficial. Write me for a copy (click on the "Trevor" link at the very bottom of this page).

"Angiotensin II and renal fibrosis"
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11566946&dopt=Abstract

"Role of angiotensin II in tubulointerstitial injury"
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11709803&dopt=Abstract

"Good news for patients with type 2 diabetes: angiotensin receptor blocker treatment delays progression of diabetic nephropathy"
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11856909&dopt=Abstract

"Retinal Neovascularization (retinopathy) Is Prevented by Blockade of the Renin-Angiotensin System"
http://hyper.ahajournals.org/cgi/content/full/36/6/1099

".. angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury"
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11723025&dopt=Abstract

Please email me if you want a full copy (31 pages) of the following reference:
"The role of angiotensin II in cognition and behaviour"
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11906704&dopt=Abstract

..Trevor..

 
 Re: Granulomas
Author: Ken (---.proxy.aol.com)
Date:   03-26-02 08:35

Trevor- I understand, but we can not ignore granuloma formation as it is the source of ACE levels. Diovan is effective with many people but it does nothing to prevent more people from cause exposure. Understanding the actual formation and substance of the granuloma (what's inside for example) will lead to more specific treatment by cause and preventions.

http://www.sydpath.stvincents.com.au/tests/ACE.htm

 
 Re: Granulomas
Author: Admin (---.gtecablemodem.com)
Date:   03-27-02 09:22

Ken,
I have written to you privately about the issues you raised. I agree 100% with the reference you gave, but I think that some of its content may be a little confusing.

The reference states, correctly, that ACE is released from the monocytes when they encounter activated T-lymphocytes (CD4-lymphocytes). Monocytes are components of fresh and active granuloma, but they do not continue to excrete ACE for ever.

Once those old granuloma (macrophages of monocytes and T-cells) are enveloped by collagen and assimilated into what we know as "fibrosis", the issue of exactly what triggering agents have been encased by the immune system becomes less relevant to ongoing patient management. Thus, after a year or two, it shouldn't matter what caused the granuloma, it has been inactivated.

This assumes, however, that there is not continuous exposure to the agent that caused the chronic inflammation. Patient education is something that all doctors should learn to do. They 'educate' diabetic patients on 'lifestyle modification', but how many sarc patients have received anything to help them avoid future pitfalls?

Sincerely,
Trevor

 Main Menu   Newer Topic  |  Older Topic 


 Need a Login? Register Here 
 User Login
 User Name:
 Password:
   
 Forgot Your Password?
Enter your email address or user name below and a new password will be sent to the email address associated with your profile.

Historical perspective on Sarcoidosis:


  1. The John's Hopkins Vasculitis Center: Prednisone Side Effects (incl. PHOTOS and PHOTOGRAPHS)
  2. Steroid-Treated patients Have higher risk of Cardiac problems
  3. "Evidence Growing That Inhaled Steroids, Like Steroid Pills, Can Cause Bone Loss"
  4. "Corticosteroids contribute to the prolongation of the disease by delaying resolution"
  5. "No data to suggest that corticosteroid therapy alters long-term disease progression"
  6. Cochrane Review - "Oral and Inhaled Corticosteroids have no discernible effect on lung function"
  7. Prednisone Improves Symptoms but not Lung Function in Sarcodiosis
  8. There is no conclusive evidence that corticosteroids affect the development of irreversible pulmonary damage
  9. Clinical Guideline For Treatment Of Arthritis Pain
  10. Angiotensin II receptor on BALF macrophages from Japanese patients with active sarcoidosis

Go to the Sarcoidosis Information Discussion Info Message Board Forum

Sarcoidosis


Privacy Policy -(C)Copyright 2002-2007 by the Autoimmunity Research Foundation   (email webmaster)
All rights reserved - Powered by Linux and Phorum